rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Mankind Pharma Ltd. - Research Center
543904 MANKIND Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22
Sales 4,753.56 4,318.80
Operating profit 1,174.66 942.72
Interest 6.28 17.62
Gross profit 1,283.94 1,013.03
EPS (Rs) 22.02 17.93
Half yearly  results in details
Sep ' 23 Sep ' 22
Other income 115.55 87.92
Stock adjustment 17.83 218.14
Raw material 443.38 385.72
Power and fuel - -
Employee expenses 981.49 849.83
Excise - -
Admin and selling expenses - -
Research and development expenses - -
Expenses capitalised - -
Other expenses 2,136.19 1,922.39
Provisions made - -
Depreciation 145.58 131.26
Taxation 256.19 163.37
Net profit / loss 882.17 718.40
Extra ordinary item - -
Prior year adjustments - -
Equity capital 40.06 40.06
Equity dividend rate - -
Agg.of non-prom. shares (Lacs) - -
Agg.of non promotoholding (%) - -
OPM (%) 24.71 21.83
GPM (%) 26.37 22.99
NPM (%) 18.12 16.30
Close
Add Mankind Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Mankind Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close